TTynixa
Internal technical assessment.تقييم تقني داخلي. This page evaluates engine depth, not marketing copy. No PHI. No final clinical output.هذه الصفحة تقيّم عمق المحرك لا النص التسويقي. لا PHI ولا مخرجات سريرية نهائية.

Technical Capability Matrixمصفوفة القدرة التقنية

Hard-question framework to determine whether Tynixa is only a polished interface or a real genomic interpretation engine with traceability, review gates, evidence reasoning, and defensible technical depth.

18Capability axes
0–5Score scale
10Critical questions
DraftHuman review required

Critical questionsالأسئلة الحاسمة

  1. Does Tynixa build traceable interpretation, or only display information?
  2. Can it convert an external PDF into variant + evidence + report draft?
  3. Does ACMG explain why each criterion is applied or not applied?
  4. Does it expose conflicts instead of hiding them?
  5. Does it state what evidence is missing?
  6. Does it have Local Variant Memory?
  7. Does Human Review Gate prevent final output?
  8. Can it run self-hosted/offline?
  9. Does every result have source, reason, and confidence?
  10. Can it produce a review-ready package within minutes?

Assessment axesمحاور التقييم

Input Layer / PDF-VCF-CSV Intake

  • VCF/PDF/CSV/Excel/Gene+Variant intake
  • PDF report extraction
  • multi-variant extraction
  • missing report detection
0–5

Variant Normalization

  • HGVS c/p/g support
  • transcript mapping
  • GRCh37/GRCh38 handling
  • SNV/Indel/CNV/SV/MT support
  • normalization uncertainty
0–5

Gene–Disease Layer

  • OMIM/Orphanet/ClinGen context
  • gene-disease confidence
  • inheritance consistency
  • rare disease/oncology/PGx context
0–5

Phenotype Engine

  • free-text phenotype understanding
  • HPO mapping
  • Arabic/English symptoms
  • phenotype match scoring
  • missing phenotype prompts
0–5

Evidence Engine

  • ClinVar/gnomAD/PubMed/OMIM/HPO/ClinGen/LOVD
  • source timestamps
  • evidence freshness
  • quality weighting
  • citation traceability
0–5

Evidence Graph

  • variant-gene-disease-phenotype-paper-ACMG graph
  • conflict detection in graph
  • graph score/export/audit
  • reuse for local memory
0–5

ACMG Reasoning Engine

  • candidate vs applied criteria
  • reason/source/confidence per criterion
  • over-classification prevention
  • ClinGen/gene-specific rules
  • draft not final
0–5

Conflict Detection

  • ClinVar conflict
  • frequency conflict
  • phenotype mismatch
  • inheritance mismatch
  • transcript/build conflict
  • escalation severity
0–5

Missing Evidence Engine

  • missing segregation/parental/phenotype/functional/QC
  • next best action
  • doctor questions
  • ACMG linkage
  • confidence impact
0–5

External PDF Report Interpretation

  • classification extraction
  • evidence rebuild
  • limitations detection
  • transcript/build/ACMG omissions
  • review package
0–5

Local Variant Memory

  • seen before
  • reviewer decisions
  • institution separation
  • versioning
  • reclassification alerts
  • anonymization
0–5

Human Review Workflow

  • reviewer roles
  • senior review
  • lab director sign-off
  • criterion accept/reject
  • audit history
  • final export lock
0–5

SOP Engine

  • lab rules
  • PP5 disable
  • PS3 senior review
  • ClinVar conflict escalation
  • thresholds/templates/versioning
0–5

Safety & Guardrails

  • no final diagnosis
  • no final treatment
  • no final ACMG without review
  • PHI detector/redaction
  • external LLM disabled
  • safety events
0–5

Explainability

  • source/criterion/evidence/confidence per output
  • why VUS/pathogenic not applied
  • what would change classification
  • doctor/lab/patient modes
0–5

Performance & Scale

  • small VCF/WES timing
  • variant prioritization
  • queue/batch
  • offline/cache
  • low bandwidth
  • no GPU requirement
0–5

Integration

  • API
  • LIS/LIMS
  • HL7/FHIR
  • PDF/Word/JSON export
  • VCF/CSV/PDF import
  • self-hosted/Docker/offline bundle
  • audit export
0–5

Report Generation

  • draft report
  • ACMG table export
  • doctor-friendly explanation
  • lab-review package
  • comparison with original classification
0–5
Safety baseline: draft-only outputs, human review required, no final diagnosis, no treatment decision, no final ACMG classification without review.